Target intelligence / Profile preview

Mucoprotein

Molecular classification
Glycoprotein, Mucin, Structural protein (in mucus)
01

Overview

Mucoproteins are a class of high-molecular-weight conjugated proteins that contain a significant proportion of carbohydrates in the form of mucopolysaccharides (more than 4% by weight). They occur in mucosal secretions (mucus) throughout the body, including the gastrointestinal and respiratory tracts, joints, and reproductive tissues. Their primary roles are to form protective, lubricating barriers on epithelial surfaces, regulate permeability, and defend against pathogens and chemical injury. Mucoprotein dysfunction is implicated in disorders characterized by excessive or deficient mucus production, such as respiratory infections, chronic diseases, and certain cancers. Drug interaction primarily occurs via the use of mucolytic agents that target mucoprotein structure to reduce secretion viscosity and improve tissue function.

Other names
MucinsConjugated proteinsGlycoproteins
02

Mechanism of action

Breaking disulfide bonds within mucoproteins to reduce viscosity (classic mucolytics); Depolymerizing DNA/F-actin in mucus plugs (peptide mucolytics)

03

Biological functions

Formation of mucus barriers (protection)Lubrication of epithelial surfacesSelective permeability (nutrient, water absorption)Protection against auto-digestion in stomachStructural and lubricating role in joint synovial fluid
04

Disease associations

Cancer (e.g., elevated in gallbladder cancer)Pulmonary/respiratory diseases (hypersecretion in asthma, COPD)Gastrointestinal disorders (altered secretion in injury, infection)InflammationInfection (barrier/defense role)
05

Safety considerations

Excess mucus production can impair airway function (asthma, COPD)Alteration of mucus barrier might increase tissue susceptibility to infection or chemical damage
06

Interacting drugs

Mucolytic agents (e.g., acetylcysteine, DNase I)

1 more in the full profile.

07

Biomarkers

MUC5AC and MUC5B (airway mucins; markers of goblet cell metaplasia and mucus secretion in asthma/COPD)Elevated mucoprotein levels (cancer biomarker, e.g., in gallbladder cancer)

Beyond the preview

Go deeper on Mucoprotein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucoprotein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call